News & Events

Zaphyr CEO, Dr Manel Chikh talking about How can technology improve the patient journey during a panel discussion with other amazing CEOs

Thank you Dr Sawsan Al Madhi, Dr Dominique Joubert and Dr Sharif Kullab for the successful roundtable on the “Latest innovations in oncology treatment: clinical research, screening and treatment in MEA in general and in the GCC in particular”. I was truly honored to moderate this session and highlight with you all the amazing innovations that are being currently launched in the region such as CancerRead test.

2Latest-innovations-in-oncology-treatment1 2Latest-innovations-in-oncology-treatment2 2Latest-innovations-in-oncology-treatment4 2Latest-innovations-in-oncology-treatment3 2Latest-innovations-in-oncology-treatment5 2Latest-innovations-in-oncology-treatment8 2Latest-innovations-in-oncology-treatment7


Zaphyr CEO, Dr Manel Chikh, talking about innovation in Oncology and moderating a very interesting panel discussion during CPhi MEA with amazing experts in the region “Latest innovations in oncology treatment: clinical research, screening and treatment »

Thank you Dr Sawsan Al Madhi, Dr Dominique Joubert and Dr Sharif Kullab for the successful roundtable on the “Latest innovations in oncology treatment: clinical research, screening and treatment in MEA in general and in the GCC in particular”. I was truly honored to moderate this session and highlight with you all the amazing innovations that are being currently launched in the region such as CancerRead test.

Latest-innovations-in-oncology-treatment3 Latest-innovations-in-oncology-treatment2 Latest-innovations-in-oncology-treatment1


Manel Chikh among other excecutive selected members of CPhi Advisory board, Kick the first Cphi Middel east & Africa congress



CPhl middle east & africa 2018 – Manel Chikh – Zaphyr Pharmaceuticals

Manel Chikh zaphyr pharmaceuticalsManel Chikh
Co-Founder and Chief Executive Officer
Zaphyr Pharmaceuticals.
CPhl middle east & africa
(3-5 September 2018 | ADNEC, Abu Dhabi, United Arab Emirates)

By representing each sector of the pharmaceutical industry, CPhI is one of the most important and supportive platforms for pharma companies.
Each CPhI event is an opportunity to meet new key players, to develop YOUR API or finished dose portfolio, to develop and expend manufacturing and/or commercialization capabilities in new territories and to receive updates on all the new trends.

Thanks to CPhI, I met many outstanding partners with whom I built a strong and successful long-term presence in the MEA region.

I fully support and recommend the launch of CPhI MEA. This event will be a fantastic opportunity to highlight the region to the wider pharma market and to give foreign companies real exposure to the potential opportunities it offers. API developers, finished dosage suppliers, CROs and manufacturers will have the chance to build strong relationships with key regional and local players to develop and increase local production, as well as to stimulate imports of high quality, effective medicines in the region.